Arvind Remedies shines on coming out with new Antiviral drug

19 Nov 2013 Evaluate

Arvind Remedies is currently trading at Rs. 55.85, up by 0.25 points or 0.45% from its previous closing of Rs. 55.60 on the BSE.

The scrip opened at Rs. 56.50 and has touched a high and low of Rs. 57.05 and Rs. 55.55 respectively. So far 22,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 59.95 on 08-Nov-2013 and a 52 week low of Rs. 24.85 on 01-Mar-2013.

Last one week high and low of the scrip stood at Rs. 58.00 and Rs. 54.90 respectively. The current market cap of the company is Rs. 269 crore.

The promoters holding in the company stood at 45.47% while Non-Institutions held 54.53%.

Arvind Remedies is coming out with the development of new Antiviral drug in collaboration with leading institutions. The drug is planned to be higher bio-availability, higher efficacy and minimum side effect, for treatment of viruses like Human Herpes virus, Varivella zoster virus, Chickenguniya and Chicken Pox. The patent application for the drug has been filed and the next step is clinical studies as per global regulatory requirements.

Arvind Remedies is engaged in the manufacturing of pharmaceutical formulations such as tablets, capsules (including soft gels), ointments and liquids. ARL markets its products in the institutional (primarily government organizations) and ethical segments, with institutional segment contributing to 70% of the total revenues.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×